$31.99 +0.02 (%) Pfizer Inc - NYSE

Dec. 19, 2014 | 12:20 PM

Partner Headlines

  1. #PreMarket Movers From December 18, 2014: Rite Aid, Oracle, GoPro And More

    Benzinga | Dec. 18, 2014 | 09:08AM EST
  2. Pfizer licenses Opko's hGH

    IBD | Dec. 15, 2014 | 18:46PM EST
  3. Opko Health Inks Pfizer License Pact

    Benzinga | Dec. 15, 2014 | 13:49PM EST
  4. Pfizer Licenses Opko's Long-Acting Growth Hormone

    IBD | Dec. 15, 2014 | 12:01PM EST
  5. Bank Of America's Top 10 Stocks For 2015

    Benzinga | Dec. 15, 2014 | 10:13AM EST
  6. Stocks Open To Mild Losses; Adobe Surges, Nabors Dives

    IBD | Dec. 12, 2014 | 10:34AM EST
  7. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  8. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  9. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  10. Pfizer Reports Expansion of Rare Disease Research with Establishment of Gene Therapy Platform

    Benzinga | Dec. 8, 2014 | 08:07AM EST
  11. Benzinga's Weekend M&A Chatter

    Benzinga | Dec. 7, 2014 | 18:24PM EST
  12. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  13. Puma Biotech Stock Plunges On Drug Filing Delay

    IBD | Dec. 3, 2014 | 11:43AM EST
  14. Fast Money Picks For December 3: Canadian Pacific, Abbott Labs, BlackBerry And Ford

    Benzinga | Dec. 3, 2014 | 07:47AM EST
  15. Pete Najarian Sees Unusual Options Activity In Pfizer

    Benzinga | Dec. 3, 2014 | 07:35AM EST
  16. Fast Money Halftime Report Final Trade From December 2

    Benzinga | Dec. 3, 2014 | 07:30AM EST
  17. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD | Dec. 2, 2014 | 17:14PM EST
  18. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD | Dec. 2, 2014 | 12:23PM EST
  19. Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Operating Margin

    Benzinga | Dec. 2, 2014 | 04:38AM EST
  20. 5 Stock-Moving Medtech Events This December

    IBD | Nov. 28, 2014 | 14:18PM EST
  21. CNBC'S Catherine Boyle Doesn't Think A Pfizer/AstraZeneca Deal Will Happen Soon

    Benzinga | Nov. 26, 2014 | 14:20PM EST
  22. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  23. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  24. Vipshop Leads 4 Top Stocks With Bolting RS Lines

    IBD | Nov. 18, 2014 | 08:02AM EST
  25. U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts

    Benzinga | Nov. 17, 2014 | 16:46PM EST
  26. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  27. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  28. #PreMarket Primer: Monday, November 17: Japan's Economy Unexpectedly Slips

    Benzinga | Nov. 17, 2014 | 08:33AM EST
  29. Pfizer Shares Trending Lower Following Lowered FY2014 EPS Guidance

    Benzinga | Nov. 17, 2014 | 08:08AM EST
  30. Guru Ken Fisher's Top Five Quarterly Stocks

    GuruFocus | Nov. 16, 2014 | 23:17PM EST
  31. Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca

    Benzinga | Nov. 14, 2014 | 09:38AM EST
  32. Ackman's Pershing Group Buys Stake in Zoetis

    GuruFocus | Nov. 13, 2014 | 11:23AM EST
  33. Ackman's Pershing Square Buys Stake in Zoetis

    GuruFocus | Nov. 13, 2014 | 11:23AM EST
  34. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus | Nov. 12, 2014 | 15:29PM EST
  35. Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis

    GuruFocus | Nov. 12, 2014 | 12:37PM EST
  36. Why Pfizer Is At A Technical 'Fork In The Road'

    Benzinga | Nov. 11, 2014 | 10:26AM EST
  37. Energy Stocks: Cash Metric Flashes “Oversold”

    YCharts | Nov. 11, 2014 | 03:43AM EST
  38. Will Pfizer Sweeten Its Bid For AstraZeneca?

    IBD | Nov. 6, 2014 | 18:41PM EST
  39. Divided Government Won't Halt Wall Street's Run

    FoxBusiness | Nov. 6, 2014 | 09:58AM EST
  40. Monotype Gets Its Font Tech Deeper Into Advertising

    IBD | Nov. 5, 2014 | 18:26PM EST
  41. Minerals Technologies Digs Up A Winner With Buyout

    IBD | Nov. 3, 2014 | 13:47PM EST
  42. The Importance of Capital Intensity and Thoughts From Einhorn

    GuruFocus | Oct. 31, 2014 | 11:35AM EST
  43. Johnson & Johnson Fairly Valued - I Will Bet on It

    GuruFocus | Oct. 30, 2014 | 12:26PM EST
  44. Buybacks-Driven Market: Engineered Too Far?

    YCharts | Oct. 29, 2014 | 12:36PM EST
  45. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond Purchases

    Benzinga | Oct. 29, 2014 | 07:50AM EST
  46. Pfizer Q3 beats views

    IBD | Oct. 28, 2014 | 18:46PM EST
  47. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  48. Fast Money Traders Take Position On Stocks Making Headlines

    Benzinga | Oct. 28, 2014 | 15:59PM EST
  49. Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

    Benzinga | Oct. 28, 2014 | 15:39PM EST
  50. Pfizer Conference Call Highlights

    Benzinga | Oct. 28, 2014 | 15:36PM EST
Trading Center